Less than two months after the listing of the first batch of SSE Kechuang100 ETFs, the second batch of SSE Kechuang100 ETFs has made progress.
65438+ 10 On October 24th, Huaxia Kechuang 100ETF, Huatai Bairui Kechuang 100ETF and Yifangda Kechuang 100ETF were officially approved. The first batch of four science and technology innovation board100 ETFs have been favored since they went public, and their scale has increased by nearly 16% in the past month.
According to industry insiders, science and technology innovation board 100ETF not only meets investors' demand for broad-based investment in the mid-market, but also complements the original science and technology innovation board ETF, further improving its broad-based product matrix. The presence of the head ETF management group also reflects the fund company's optimism about the value of index investment.
A number of people interviewed in Public Offering of Fund said that China's science and technology industry is entering a new round of innovation cycle, which will generate a series of investment opportunities and be optimistic about the long-term development space of science and technology innovation board.
The second batch of Kechuang 100ETF was approved soon.
124 October, 10, the 100ETF of science and technology innovation of Huaxia, Yifangda and Huatai Bairui was officially approved, just one month after it was reported. It is understood that this is the second batch of Kechuang 100 index products after the first batch of four science and technology innovation board100 ETFs went public on September 5th.
Since the opening of the market on 20 19, the market scale of science and technology innovation board has expanded rapidly. At present, there are 562 listed companies with a total market value of more than 6 trillion yuan. The market demand for investment in science and technology innovation board is increasing day by day.
It is reported that the Kechuang 100 index contains 100 high-quality targets with medium market value and good liquidity, and the average market value of constituent stocks is between CSI 500- CSI 1000. The market value characteristics of small and medium-sized stocks are obvious, which is obviously different from Kechuang 50.
From the perspective of industry distribution, the science and technology innovation board 100 index covers the scientific and technological core sectors such as pharmaceutical biology (30.6%), power equipment (19.7%) and electronics (18.6%) in a balanced way, which is highly coincident with the national strategic emerging industries. At the same time, compared with the science and technology innovation board, constituent stocks have strong advantages in R&D investment and revenue growth, which further highlights the "hard technology" background that emphasizes R&D, high growth and high flexibility.
"With the rapid expansion of the science and technology innovation board market, the representativeness of the science and technology 50 index to its overall performance began to decline. At present, the market value coverage of free circulation is only 40.72%. Therefore, the release of Science and Technology Innovation 100 Index is timely. Through the free circulation market value coverage rate of 25.2 1%, the gap left by the science and technology innovation 50 index is made up to some extent, and the index structure system of the science and technology innovation board market is enriched. " Huatai Bairui Fund said.
Talking about the future development trend of Kechuang 100 index products, Huatai Bai Rui said that since the beginning of this year, the attention of the constituent stocks of Kechuang 100 index has been significantly improved. Especially since the second half of the year, under the pressure of market adjustment, northbound funds have accelerated the allocation of 100 index stocks. At the same time, at present, Public Offering of Fund is in a low allocation position for the constituent stocks of the science and technology innovation 100 index, and the future science and technology innovation 100 index is expected to receive considerable incremental financial support.
The first batch of100 ETFs grew rapidly.
Judging from the performance of the first four science and technology innovation board100 ETFs since their listing, science and technology innovation board100 ETFs are favored by the market.
Judging from the scale of fundraising, the first batch of four technology100 ETFs "attracted gold" of nearly 7 billion yuan. Among them, the issuance scale of Bosera SSE science and technology innovation board 100ETF is 266 1 100 million yuan, which is the largest fundraising scale; The issuance scales of Guotai Fund, Yin Hua Fund and Penghua Fund are 654.38+49.2 million yuan, 654.38+35.8 million yuan and 654.38+44 million yuan respectively, which are outstanding in the relatively depressed fund issuance market this year.
On September 15, the first batch of four SSE Kechuang100 ETFs under cathay pacific fund, Bosera Fund, Yin Hua Fund and Penghua Fund were officially listed. Judging from the performance on the first day, the overall transaction was active, with a total transaction of1800 million yuan.
As of1October 24th 10, it has been more than one month since the first batch of 4100 ETFs went public. From the perspective of scale changes, the latest scale of the first batch of 4100 ETFs totaled 8.033 billion yuan, an increase of nearly 16% compared with the scale raised.
In addition, the layout of Kechuang 100ETF is constantly improving. 10 10 16, kechuang 100ETF was officially included in the margin trading target, which means that more trading funds will flood in, further enhancing the activity and liquidity in the market. At the same time, recently, four science and technology innovation 100ETF connection funds have also been officially approved. OTC investors can also buy through banks, tripartite sales and other channels to lay out high-tech industries on a "base".
"In the past two years, affected by internal and external factors, A shares continued to be under pressure, and the technology sector was in the forefront of adjustment. The adjustment time and range are enough, and the valuation pressure has been fully released. With the cyclical demand of the electronics industry picking up and the pharmaceutical industry stabilizing and picking up, science and technology innovation board's profit is expected to gradually pick up. The Science and Technology Innovation 50 and Science and Technology Innovation 100 index, which were under heavy pressure in the early stage, have great resilience. " Huaxia Fund said.
David moses, fund manager of Bosera Fund Index and Quantitative Investment Department, said that science and technology innovation board is a place where high-tech enterprises are concentrated, which can be called the "main battlefield" of hard technology. Kechuang 100 index ETF was officially listed in September this year, and it was officially included in two financial targets a few days ago. At present, it is the largest ETF product of its kind, with leading liquidity.
Future investment opportunities of science and technology innovation board are promising.
Statistics show that as of June 24th, 10, the scale of related index products of science and technology innovation board in the whole market has exceeded180 billion yuan.
Since the beginning of this year, the market has been constantly adjusted, and the enthusiasm for funds to be distributed through ETFs in science and technology innovation board is high. The data shows that as of June 24th 10, the overall share of ETFs tracking the technology index has increased by 1048 billion copies this year, among which the share of ETFs tracking the technology 50 index has increased by over 76 billion copies. This may also be one of the reasons why the related products of Kechuang 100 index, which is known as "the second largest base of science and technology innovation board", have attracted much attention.
Pang Yaping, general manager of the index research department of E Fund, said that under the background of the high-level accelerated development of science and technology, the science and technology innovation board that gathers "hard technology" enterprises contains rich investment opportunities and continues to be favored by funds.
Huaxia Fund said that the current economic development direction of China is gradually shifting from "high-speed development" to "high-quality development". With the gradual weakening of traditional dividends such as population and urbanization, technological innovation will become an important engine of China's economic growth in the future. Faced with the complex changes in the international situation, domestic substitution in the field of scientific and technological innovation is the general trend, and emerging scientific and technological industries will surely become an important development direction in the future.
Huatai Bairui Fund said that after three years of correction, the science and technology innovation board is still at a low level. Looking back, a new round of domestic economic stimulus policies is ready to go. In the case of insufficient kinetic energy of traditional industries, emerging industries mapped by science and technology innovation board may become the core force to stimulate economic growth. On the other hand, the science and technology industry represented by artificial intelligence is gradually moving from the imagination-driven valuation stage to the application stage, which is expected to effectively promote China's economic restructuring and industrial transformation and upgrading. In this development path, the science and technology innovation board may become a key position.